课题基金 / 基金详情

Treating progressive multiple sclerosis

Treating progressive multiple sclerosis
治疗进行性多发性硬化症
批准号:
nhmrc : 1083539
负责人:
Dr Tim Spelman
金额:
$33.62万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2018-12-31

项目摘要

项目成果

Dr Tim Spelman的其他基金

相似基金

相关文献

中文摘要
翻译
虽然有许多治疗复发缓解型多发性硬化症(MS),治疗进展MS仍然难以捉摸。该项目将评估各种治疗对进行性MS中不可逆残疾积累的影响。此外,它将检查治疗之间的转换对MS活动的影响。最后,该项目将表明人口统计学和临床信息是否可用作个体患者对MS治疗反应的预测因子。
英文摘要
While there are numerous therapies for relapsing-remitting multiple sclerosis (MS), therapy for progressive MS remains elusive. This project will evaluate the effect of various therapies on the accumulation of irreversible disability in progressive MS. In addition, it will examine the effect of switching between therapies on MS activity. Finally, the project will indicate whether demographic and clinical information can be used as a predictor of individual patient response to MS therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Eliminating HCV: statistical modelling and health economic evaluation in the new DAA era
  • 批准号:
    nhmrc : GNT1130685
  • 项目类别:
    Early Career Fellowships
  • 资助金额:
    $31.88万
  • 财政年份:
    2017
  • 负责人:
    Dr Tim Spelman
  • 依托单位:
Eliminating HCV: statistical modelling and health economic evaluation in the new DAA era
Networks analysis - modelling transmission of disease and propagation of adverse health outcomes through interconnected populations
海外基金